Dermatologia
Diretriz | Tratamento da urticária
7 Fev, 2023 | 15:32h
Consenso | Revisão do sistema de classificação para relatórios sobre biópsias cutâneas de lesões melanocíticas
16 Jan, 2023 | 10:55hComentários:
MPATH-Dx Version 2.0 Simplifies Classification of Melanoma – HealthDay
Comentário no Twitter
American and international #dermatopathologists revise Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis schema. MPATH-Dx V2.0 improves standardized diagnostic reporting and patient management of #melanoma. https://t.co/G0fluzq5fs
— JAMA Network Open (@JAMANetworkOpen) January 12, 2023
Estudo randomizado | Lebriquizumabe combinado com corticosteroides tópicos em adolescentes e adultos com dermatite atópica moderada a grave
16 Jan, 2023 | 10:48h
Comentário no Twitter
Does blocking the IL-13 cytokine w/ lebrikizumab combined w/ topical therapy provide clinical benefit in atopic eczema? This study reflecting real-world use patterns suggests a benefit. https://t.co/apUvYO3Jqv
— JAMA Dermatology (@JAMADerm) January 13, 2023
Estudo randomizado | Filme de mepitel na prevenção de dermatite aguda por radiação no câncer de mama.
13 Dez, 2022 | 15:10hMepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)
Estudo randomizado | Intervenções de cuidados cutâneos em bebês para prevenir eczema e alergia alimentar.
13 Dez, 2022 | 14:57hSkin care interventions in infants for preventing eczema and food allergy – Cochrane Library
Resumo: Skin care interventions for preventing eczema and food allergy – Cochrane Library
Comentário no Twitter
Read our newest review on skin care interventions in infants for preventing eczema and food allergy! https://t.co/o8HtBXRVM5 pic.twitter.com/BPzsjJZvTf
— Cochrane Skin (@CochraneSkin) November 15, 2022
Seminário | Varíola dos macacos.
28 Nov, 2022 | 15:00hComentários:
Study shows there is substantial monkeypox transmission before symptoms appear.
Monkeypox – New England Journal of Medicine
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health
CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.
Update on the Monkeypox Outbreak – JAMA
WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch
Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases
Comentário no Twitter
Seminar: Monkeypox
In light of the 2022 global outbreak, @oriolmitja and colleagues provide an overview of epidemiology, clinical presentation, treatment, prevention, and more.
📌 https://t.co/gB0fcokA8D pic.twitter.com/Db3ZsU4ykt
— The Lancet (@TheLancet) November 22, 2022
Aperfeiçoando a gestão de antibióticos com teste de alergia à penicilina: revisão das práticas atuais e necessidades não supridas.
28 Nov, 2022 | 14:51hConteúdos relacionados:
M-A: Most patients with allergy to Penicillin can be given Cefazolin
Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy
Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule
NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk
Revisão sistemática | Intervenções para prevenção de longo prazo dos ataques de angioedema hereditários.
28 Nov, 2022 | 14:39hInterventions for the long‐term prevention of hereditary angioedema attacks – Cochrane Library
Resumo: Drug treatments for the prevention of attacks of hereditary angioedema – Cochrane Library
Comentário no Twitter
New #CochraneEvidence – Interventions for the long‐term prevention of #HereditaryAngioedema attacks #HAE @CochraneUK @CochraneLibrary @US_HAEA @UCSDHealth @HAEDAY @VSGBI @ChariteBerlin https://t.co/jYYjmG1eGH pic.twitter.com/2z522Bw5iZ
— CochraneVasc (@CochraneVasc) November 7, 2022
Câncer de pele em receptores de transplante de órgãos sólidos: revisão para o não dermatologista.
28 Nov, 2022 | 14:20h
M-A | Incidência de eventos adversos cutâneos com inibidores de fosfoinositida 3-quinase como terapia adjuvante em pacientes oncológicos.
17 Out, 2022 | 13:50hIncidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysis – JAMA Oncology (gratuito por tempo limitado)